187 related articles for article (PubMed ID: 31008415)
1. Physiologically based mathematical models of nanomaterials for regulatory toxicology: A review.
Lamon L; Asturiol D; Vilchez A; Cabellos J; Damásio J; Janer G; Richarz A; Worth A
Comput Toxicol; 2019 Feb; 9():133-142. PubMed ID: 31008415
[TBL] [Abstract][Full Text] [Related]
2. Computational models for the assessment of manufactured nanomaterials: Development of model reporting standards and mapping of the model landscape.
Lamon L; Asturiol D; Vilchez A; Ruperez-Illescas R; Cabellos J; Richarz A; Worth A
Comput Toxicol; 2019 Feb; 9():143-151. PubMed ID: 31008416
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Use of Physiologically-Based Kinetics Modelling to Reliably Predict Internal Concentrations of the UV Filter, Homosalate, After Repeated Oral and Topical Application.
Najjar A; Schepky A; Krueger CT; Dent M; Cable S; Li H; Grégoire S; Roussel L; Noel-Voisin A; Hewitt NJ; Cardamone E
Front Pharmacol; 2021; 12():802514. PubMed ID: 35058784
[TBL] [Abstract][Full Text] [Related]
5. Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications.
Paini A; Leonard JA; Kliment T; Tan YM; Worth A
Regul Toxicol Pharmacol; 2017 Nov; 90():104-115. PubMed ID: 28866268
[TBL] [Abstract][Full Text] [Related]
6. Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.
Paini A; Leonard JA; Joossens E; Bessems JGM; Desalegn A; Dorne JL; Gosling JP; Heringa MB; Klaric M; Kliment T; Kramer NI; Loizou G; Louisse J; Lumen A; Madden JC; Patterson EA; Proença S; Punt A; Setzer RW; Suciu N; Troutman J; Yoon M; Worth A; Tan YM
Comput Toxicol; 2019 Feb; 9():61-72. PubMed ID: 31008414
[TBL] [Abstract][Full Text] [Related]
7. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.
Najjar A; Punt A; Wambaugh J; Paini A; Ellison C; Fragki S; Bianchi E; Zhang F; Westerhout J; Mueller D; Li H; Shi Q; Gant TW; Botham P; Bars R; Piersma A; van Ravenzwaay B; Kramer NI
Arch Toxicol; 2022 Dec; 96(12):3407-3419. PubMed ID: 36063173
[TBL] [Abstract][Full Text] [Related]
8. Gaining acceptance in next generation PBK modelling approaches for regulatory assessments - An OECD international effort.
Paini A; Tan YM; Sachana M; Worth A
Comput Toxicol; 2021 May; 18():100163. PubMed ID: 34027244
[TBL] [Abstract][Full Text] [Related]
9. Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamics.
Jeong SH; Jang JH; Lee YB
Environ Pollut; 2022 Nov; 312():120041. PubMed ID: 36030954
[TBL] [Abstract][Full Text] [Related]
10. Application of biotic ligand and toxicokinetic-toxicodynamic modeling to predict the accumulation and toxicity of metal mixtures to zebrafish larvae.
Gao Y; Feng J; Han F; Zhu L
Environ Pollut; 2016 Jun; 213():16-29. PubMed ID: 26874871
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
Dixit R; Riviere J; Krishnan K; Andersen ME
J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
[TBL] [Abstract][Full Text] [Related]
12. Impact of in vitro experimental variation in kinetic parameters on physiologically based kinetic (PBK) model simulations.
Punt A; Bos P; Hakkert B; Louisse J
ALTEX; 2023; 40(2):237–247. PubMed ID: 35901496
[TBL] [Abstract][Full Text] [Related]
13. Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate.
Fragki S; Piersma AH; Westerhout J; Kienhuis A; Kramer NI; Zeilmaker MJ
Regul Toxicol Pharmacol; 2022 Dec; 136():105267. PubMed ID: 36367522
[TBL] [Abstract][Full Text] [Related]
14. Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum.
Laroche C; Aggarwal M; Bender H; Benndorf P; Birk B; Crozier J; Dal Negro G; De Gaetano F; Desaintes C; Gardner I; Hubesch B; Irizar A; John D; Kumar V; Lostia A; Manou I; Monshouwer M; Müller BP; Paini A; Reid K; Rowan T; Sachana M; Schutte K; Stirling C; Taalman R; van Aerts L; Weissenhorn R; Sauer UG
Regul Toxicol Pharmacol; 2018 Nov; 99():5-21. PubMed ID: 30144470
[TBL] [Abstract][Full Text] [Related]
15. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
[TBL] [Abstract][Full Text] [Related]
16.
Algharably EA; Di Consiglio E; Testai E; Pistollato F; Mielke H; Gundert-Remy U
Front Toxicol; 2022; 4():885843. PubMed ID: 35924078
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based toxicokinetic and toxicodynamic (PBTK-TD) modelling of Cd and Pb exposure in adult zebrafish Danio rerio: Accumulation and toxicity.
Zhang Y; Feng J; Gao Y; Liu X; Qu L; Zhu L
Environ Pollut; 2019 Jun; 249():959-968. PubMed ID: 30965548
[TBL] [Abstract][Full Text] [Related]
19. A generic avian physiologically-based kinetic (PBK) model and its application in three bird species.
Baier V; Paini A; Schaller S; Scanes CG; Bone AJ; Ebeling M; Preuss TG; Witt J; Heckmann D
Environ Int; 2022 Nov; 169():107547. PubMed ID: 36179644
[TBL] [Abstract][Full Text] [Related]
20. Development of a rat physiologically based kinetic model (PBK) for three organophosphate flame retardants (TDCIPP, TCIPP, TCEP).
Deepika D; Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2023 Jul; 383():128-140. PubMed ID: 37356742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
